• SAVA

Cassava shares plunge 85% as Alzheimer's study fails to meet endpoints

• SAVA

Cassava Sciences shares drop in pre-open trade after $40 mln SEC settlement

Cassava Sciences, Inc. stock fell 11.5% following a $40 million SEC settlement over disclosure negligence, amidst ongoing investigations and upcoming leadership transitions.

• BMY
• COST
• DG
• ESTA
• HPQ
• SAVA
• UDMY
• WYNN

Costco dips premarket; Bristol-Myers Squibb, Wynn Resorts rise

US stock futures were steady while investors awaited economic data. Key stock movers included Costco, Bristol-Myers Squibb, and Wynn Resorts, highlighting mixed earnings and regulatory news.

• SAVA

Cassava Sciences shares fall after SEC charges for misleading Alzheimer's drug trial claims

Cassava Sciences faces SEC charges for misleading Alzheimer's trial results, leading to a 10% stock drop and significant financial penalties for the company and its executives.